Clinical trials using cord-blood units from two different donors to increase the number of stem cells infused in a single transplant show that cells from one unit may dominate the other, although both can attack the host's immune system. This phenomenon, which seems to facilitate grafting and boost the rate of hematopoiesis, is the subject of ongoing research.